Response to Comment on "Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells".

Engelberts, Patrick J; Breij, Esther C W; Valerius, T; Schuurman, J; Parren, Paul W H I; Beurskens, F J

Engelberts, Patrick J; Breij, Esther C W; Valerius, T; Schuurman, J; Parren, Paul W H I; Beurskens, F J.

Afiliação

Engelberts PJ; Genmab, 3584 CM Utrecht, The Netherlands.
Breij ECW; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
Valerius T; Genmab, 3584 CM Utrecht, The Netherlands.
Schuurman J; Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, Christian Albrechts University, 24105 Kiel, Germany.
Parren PWHI; Genmab, 3584 CM Utrecht, The Netherlands.
Beurskens FJ; Genmab, 3584 CM Utrecht, The Netherlands; p.w.h.i.parren@lumc.nl.

J Immunol ; 200(8): 2517, 2018 04 15.

Article em En | MEDLINE | ID: mdl-29632251

Assuntos

Antígenos CD20; Receptores de Antígenos de Linfócitos B; Linfócitos B; Proteínas do Sistema Complemento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Antígenos CD20 Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google